0000899243-22-006824.txt : 20220217
0000899243-22-006824.hdr.sgml : 20220217
20220217172245
ACCESSION NUMBER: 0000899243-22-006824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220217
DATE AS OF CHANGE: 20220217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Humphrey Jeffrey
CENTRAL INDEX KEY: 0001816944
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 22649507
MAIL ADDRESS:
STREET 1: C/O CONSTELLATION PHARMACEUTICALS, INC.
STREET 2: 215 FIRST STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Magenta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-15
0
0001690585
Magenta Therapeutics, Inc.
MGTA
0001816944
Humphrey Jeffrey
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
3.19
2022-02-15
4
A
0
75000
0.00
A
2032-02-14
Common Stock
75000
75000
D
This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is February 1, 2022.
/s/ Cindy Driscoll, Attorney-in-Fact for Jeffrey Humphrey
2022-02-17